NEVVI Medicare utilization intelligence

← back

AHMAD, HAMADMD NPI 1013271485 Clinician

Family Practice · MILLINGTON, TN

Specialty Family Practice — from billed Medicare claims
In practice about 20 years since medical school (class of 2006, self-reported to CMS)
Location MILLINGTON, TN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 42 codes billed · 16,536 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
2019–2026
2020–2021
2020

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-09

Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
95144 Professional service for preparation and provision of single-dose vial of allergen premiumpremium premiumpremium
J1010 Injection, methylprednisolone acetate, 1 mg premiumpremium premiumpremium
95004 Test for allergy using allergenic extract premiumpremium premiumpremium
95165 Professional service for preparation and provision of 1 or more antigens premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
87804 Detection test by immunoassay with direct visual observation for influenza virus premiumpremium premiumpremium
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
82962 Blood glucose (sugar) test performed by hand-held instrument premiumpremium premiumpremium
J0696 Injection, ceftriaxone sodium, per 250 mg premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
81003 Automated urinalysis test premiumpremium premiumpremium
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
J1885 Injection, ketorolac tromethamine, per 15 mg premiumpremium premiumpremium
71046 X-ray of chest, 2 views premiumpremium premiumpremium
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) premiumpremium premiumpremium
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes premiumpremium premiumpremium
99497 Advance care planning, first 30 minutes premiumpremium premiumpremium
99453 Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment premiumpremium premiumpremium
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days premiumpremium premiumpremium
G0442 Annual alcohol misuse screening, 5 to 15 minutes premiumpremium premiumpremium
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report premiumpremium premiumpremium
G0444 Annual depression screening, 5 to 15 minutes premiumpremium premiumpremium
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit premiumpremium premiumpremium
94640 Inhalation treatment for airway obstruction or sputum production premiumpremium premiumpremium
87631 Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
J1030 Injection, methylprednisolone acetate, 40 mg premiumpremium premiumpremium
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg premiumpremium premiumpremium
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram premiumpremium premiumpremium
80305 Testing for presence of drug, read by direct observation premiumpremium premiumpremium
G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes premiumpremium premiumpremium
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme premiumpremium premiumpremium
69210 Removal of impacted ear wax premiumpremium premiumpremium
87807 Detection test by immunoassay with direct visual observation for respiratory syncytial virus premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
93308 Ultrasound of heart, follow-up premiumpremium premiumpremium
G0447 Face-to-face behavioral counseling for obesity, 15 minutes premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.